User profiles for Natasha D. Durham

Natasha D. Durham

University of Massachusetts Medical School
Verified email at umassmed.edu
Cited by 525

[HTML][HTML] Conformational changes in the Ebola virus membrane fusion machine induced by pH, Ca2+, and receptor binding

DK Das, U Bulow, WE Diehl, ND Durham… - PLoS …, 2020 - journals.plos.org
The Ebola virus (EBOV) envelope glycoprotein (GP) is a membrane fusion machine required
for virus entry into cells. Following endocytosis of EBOV, the GP1 domain is cleaved by …

Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics

ND Durham, A Agrawal, E Waltari, D Croote, F Zanini… - Elife, 2019 - elifesciences.org
Eliciting broadly neutralizing antibodies (bNAbs) against the four dengue virus serotypes (DENV1-4)
that are spreading into new territories is an important goal of vaccine design. To …

Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tail

ND Durham, AW Yewdall, P Chen, R Lee… - Journal of …, 2012 - Am Soc Microbiol
Human immunodeficiency virus type 1 (HIV-1) infection can spread efficiently from infected
to uninfected T cells through adhesive contacts called virological synapses (VSs). In this …

P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines interleukin-10 (IL-10) and IL-1β in a human tonsil explant model

AY Soare, ND Durham, R Gopal, B Tweel… - Journal of …, 2019 - Am Soc Microbiol
HIV-1 causes a persistent infection of the immune system that is associated with chronic
comorbidities. The mechanisms that underlie this inflammation are poorly understood. Emerging …

P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection

TH Swartz, AM Esposito, ND Durham… - Journal of …, 2014 - Am Soc Microbiol
Human immunodeficiency virus type 1 (HIV-1) infection is chronic and presently still incurable.
Antiretroviral drugs effectively suppress replication; however, persistent activation of …

[HTML][HTML] Real-time analysis of individual Ebola virus glycoproteins reveals pre-fusion, entry-relevant conformational dynamics

ND Durham, AR Howard, R Govindan, F Senjobe… - Viruses, 2020 - mdpi.com
The Ebola virus (EBOV) envelope glycoprotein (GP) mediates the fusion of the virion
membrane with the membrane of susceptible target cells during infection. While proteolytic …

HIV-1 cell-free and cell-to-cell infections are differentially regulated by distinct determinants in the Env gp41 cytoplasmic tail

ND Durham, BK Chen - Journal of virology, 2015 - Am Soc Microbiol
The HIV-1 envelope (Env) glycoprotein mediates viral entry during both cell-free and cell-to-cell
infection of CD4 + T cells. The highly conserved long cytoplasmic tail (CT) of Env is …

Postintegration HIV-1 infection of cervical epithelial cells mediates contact-dependent productive infection of T cells

…, C Zony, RA Alvarez, ND Durham… - The Journal of …, 2013 - academic.oup.com
The female genital epithelium plays a protective role against invading pathogens; however,
sexual transmission of human immunodeficiency virus type 1 (HIV-1) still occurs in healthy …

[HTML][HTML] A high throughput Cre–lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry

…, P Cheung, TH Swartz, H Li, T Tsibane, ND Durham… - Virology, 2016 - Elsevier
Enveloped virus entry occurs when viral and cellular membranes fuse releasing particle
contents into the target cell. Human immunodeficiency virus (HIV) entry occurs by cell-free virus …

[HTML][HTML] Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgG

RA Alvarez, AM Maestre, K Law, ND Durham… - JCI insight, 2017 - ncbi.nlm.nih.gov
HIV-1 viremic controllers (VC) spontaneously control infection without antiretroviral treatment.
Several studies indicate that IgG Abs from VCs induce enhanced responses from immune …